Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_assertion type Assertion NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_head.
- NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_provenance.
- NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_assertion evidence source_evidence_literature NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_provenance.
- NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_assertion SIO_000772 11460166 NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_provenance.
- NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_assertion wasDerivedFrom befree-20140225 NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_provenance.
- NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_assertion wasGeneratedBy ECO_0000203 NP363389.RAex306d-Ua35ngZo3TgCq5fV5PlqV0eRFnvuTul0kVKI130_provenance.